Expression of OPN by orthotopically injected breast cancer cells is a necessary factor for the occurrence of bone marrow-derived stem cell mobilization, raising the possibility that this protein is not merely a passive biomarker [135,263]. The gene discussed is SPP1; the disease is breast cancer.